Globus Medical
Stock
Stock
ISIN: US3795772082
Ticker: GMED
US3795772082
GMED
Price
Price
CHART BY
Frequently asked questions
What is Globus Medical's market capitalization?
The market capitalization of Globus Medical is $11.43B. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.
What is Globus Medical's Price-to-Earnings (P/E) ratio?
The Price-to-Earnings (P/E) ratio (TTM) for Globus Medical is 126.61. This ratio helps investors assess whether a stock is overvalued or undervalued compared to its earnings.
What is the Earnings Per Share (EPS) for Globus Medical?
Globus Medical's Earnings Per Share (EPS) over the trailing twelve months (TTM) is $0.663. EPS indicates the company's profitability on a per-share basis.
What are the analyst ratings and target price for Globus Medical's stock?
Currently, 17 analysts cover Globus Medical's stock, with a consensus target price of $95.46. Analyst ratings provide insights into the stock's expected performance.
What is Globus Medical's revenue over the trailing twelve months?
Over the trailing twelve months, Globus Medical reported a revenue of $2.48B.
What is the EBITDA for Globus Medical?
Globus Medical's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is $438.16M. EBITDA measures the company's overall financial performance.
What is the free cash flow of Globus Medical?
Globus Medical has a free cash flow of $293.77M. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.
How many employees does Globus Medical have, and what sector and industry does it belong to?
Globus Medical employs approximately 5,000 people. It operates in the Health Care sector, specifically within the Medical Specialties industry.
What is the free float of Globus Medical's shares?
The free float of Globus Medical is 112.93M. Free float refers to the number of shares available for public trading, excluding restricted shares.
Financials
- Market Cap
- $11.43B
- EPS (TTM)
- $0.663
- Free Float
- 112.93M
- P/E ratio (TTM)
- 126.61
- Revenue (TTM)
- $2.48B
- EBITDA (TTM)
- $438.16M
- Free Cashflow (TTM)
- $293.77M
Pricing
- 1D span
- $83.19$84.52
- 52W span
- $49.35$87.00
Analyst Ratings
The price target is $95.46 and the stock is covered by 17 analysts.
Buy
11
Hold
4
Sell
2
Information
Globus Medical, Inc. operates as a medical device company that develops and commercializes healthcare solutions. The firm engages in developing products that promote healing in patients with musculoskeletal disorders. It classifies products into Innovative Fusion and Disruptive Technology. It operates through the United States and International geographical segments. The company was founded by David C. Paul, David D. Davidar and Andrew Iott in March 2003 and is headquartered in Audubon, PA.
- Employees
- 5,000
- Industries
- Medical Specialties
- Sector
- Health Care
Identifier
- ISIN
- US3795772082
- Primary Ticker
- GMED